WPI 3331 (Bupropion Extended-Release (XL) 150 mg)
Pill imprint WPI 3331 has been identified as Bupropion hydrochloride extended-release (XL) 150 mg.
Bupropion is used in the treatment of sexual dysfunction, ssri induced; major depressive disorder; depression; adhd; obesity (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- WPI 3331
- 150 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antidepressants
Smoking cessation agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
methacrylic acid - ethyl acrylate copolymer (1:1) type a
|NDC Code||Manufacturer / Repackager|
|21695-0279||Rebel Distributors Corp (repackager)|
|33261-0449||Aidarex Pharmacuticals, LLC (repackager)|
|54868-5927||Physicians Total Care Inc (repackager)|
|33261-0680||Aidarex Pharmacuticals, LLC (repackager)|
Note: Inactive ingredients may vary.
More about bupropion
- Bupropion extended-release tablets
- Bupropion hydrobromide extended-release tablets
- Bupropion sustained-release tablets
- Bupropion (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.